Thatch Raises $108 Million as Health Benefits Startup Hits $1 Billion Valuation

Thatch, a San Francisco-based health benefits platform, has raised a $108 million Series C at a $1 billion valuation, led by The General Partnership, Index Ventures, Scale Venture Partners, and General Catalyst. The round brings Thatch's total funding well past its prior $84.5 million raised across a pre-seed, Series A, and Series B.

Co-founded in 2021 by CEO Chris Ellis and Adam Stevenson, Thatch provides employers with Individual Coverage Health Reimbursement Arrangement (ICHRA) plans, letting companies set a tax-free monthly allowance for employees who then choose their own medical, dental, and vision coverage from a marketplace, plus a debit card to spend remaining balances. The model reached unicorn status roughly two years after its Series A, a fast trajectory for a benefits-administration company.

Solving a structural problem in how health insurance gets sold

Ellis has described the core issue as one of misaligned incentives: employer-sponsored insurance was built for HR departments managing a single group plan, not for individual employees with different needs, family situations, and provider preferences. ICHRA plans flip that structure, letting each employee choose from the full individual insurance market with employer-funded, tax-free dollars, a model that portability advocates have pushed for years but that required both regulatory groundwork and a consumer-grade product to gain real adoption.

Why four investors co-leading signals genuine conviction, not hedged bets

Four firms, The General Partnership, Index Ventures, Scale Venture Partners, and General Catalyst, co-leading a single Series C is an unusually wide lead group for a round of this size, and it points to a specific dynamic in how regulated fintech and insurtech rounds get built: each firm often brings a different piece of domain expertise, regulatory relationships, employer-benefits distribution, or balance-sheet capacity that the company needs simultaneously rather than sequentially. That structure is more common in categories where the product has to satisfy multiple stakeholders at once, in Thatch's case employers, employees, insurance carriers, and regulators, than in categories with a single, simpler buyer. The reformation of ICHRA regulation over the past several years, which expanded which employers can legally offer this benefit structure, is itself the kind of regulatory tailwind that makes a four-firm lead group more willing to move quickly once a product proves it can execute against the opportunity.

What this means for founders

Thatch's climb from a $38 million Series A to a $1 billion Series C valuation in roughly two years is a useful benchmark for founders in regulated, structurally complex markets: the company spent its early rounds proving out a genuinely new distribution model (ICHRA) rather than a faster version of an existing one, and investor conviction scaled once that model showed real adoption. For founders building in health benefits, insurance, or other categories where the product has to work simultaneously for employers, employees, and a regulatory framework, Thatch's sequencing, regulatory-aware product first, consumer experience second, scale third, is a more repeatable playbook than trying to do all three at once.

Healthtech and insurtech investors can be found on the investor directory, and the free investor matching tool scores fit for regulated, benefits-adjacent businesses. Background on how funding stages compound into a unicorn valuation is in the glossary entry on post-money valuation. Currently live raises are on the live listings page, and broader healthtech funding activity is tracked on the newsroom.

Find investors who are actively deploying by creating your pitch listing on AngelLinx @ angellinx.ai/register.

AngelLinx Intelligence | angellinx.ai